Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss decreased by 30% and net ...

President Trump’s approach to correcting Biden shortcomings on immigration, inflation and budget policies look sloppy. | ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...

today announced that an abstract highlighting data supporting the immune component of amezalpat’s purported mechanism of action has been accepted for poster presentation at the 2025 American ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

All statements that are not historical facts are forward-looking statements, including any statements regarding: the design, initiation, progress, timing, scope and results of clinical trials ...

All statements that are not historical facts are forward-looking statements, including any statements regarding: the design, initiation, progress, timing, scope and results of clinical trials, ...

After the American citizen, who had been kept in captivity for two ... The FBI website on Sunday still featured a wanted ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

The most subscribed YouTuber in the world, Mr Beast, has arrived in Ghana and an exciting video announcing his arrival has ...

--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology presents five scientific posters at the 2025 American ... and progress of its early ...